{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:34Z","timestamp":1791357334474,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003495.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000}}],"reference-count":77,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003495.pub3","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T19:27:52Z","timestamp":1334258872000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Intravenous secretin for autism spectrum disorders (ASD)"],"prefix":"10.1002","volume":"2012","author":[{"given":"Katrina","family":"Williams","sequence":"first","affiliation":[{"name":"Royal Children's Hospital; Department of Developmental Medicine; Flemington Rd Parkville Victoria Australia 3052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Wray","sequence":"additional","affiliation":[{"name":"Women's and Children's Health Service; State Child Development Centre; West Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M","family":"Wheeler","sequence":"additional","affiliation":[{"name":"c\/o Cochrane Developmental, Psychosocial and Learning Problems Group; Belfast Northern Ireland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015493412224","article-title":"Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism","volume":"32","author":"Carey","year":"2002","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003495.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1005443119324","article-title":"Secretin and autism: a two-part clinical investigation","volume":"30","author":"Chez","year":"2000","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mpd.2001.112474","article-title":"A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism","volume":"138","author":"Coniglio","year":"2001","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD003495.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/000992280104000604","article-title":"A double-blind, placebo-controlled cross-over study investigating the effect of porcine secretin in children with autism","volume":"40","author":"Corbett","year":"2001","journal-title":"Clinical Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD003495.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1469-8749.2000.tb00692.x","article-title":"Effect of secretin on children with autism: a randomised controlled trial","volume":"42","author":"Dunn-Geier","year":"2000","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1015441428154","article-title":"Efficacy of porcine secretin in children with autism and pervasive developmental disorder","volume":"32","author":"Kern","year":"2002","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"8","key":"10.1002\/14651858.CD003495.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/adc.88.8.731","article-title":"Children with autistic spectrum disorders. I:comparison of placebo and single dose of human synthetic secretin","volume":"88","author":"Levy","year":"2003","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD003495.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1021202930206","article-title":"Lack of benefit of intravenous synthetic human secretin in the treatment of autism","volume":"32","author":"Molloy","year":"2002","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0009|cit9","unstructured":"NCT00036244 A phase III, randomised, double blind, placebo-controlled, multiple dose study to assess the efficacy, safety and tolerability of RG1068 (synthetic human secretin) in children with autism ClinicalTrials.gov: www.clinicaltrials.gov\/ct2\/show\/NCT00036244"},{"issue":"11","key":"10.1002\/14651858.CD003495.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00004583-200111000-00009","article-title":"Multisite, double-blind placebo-controlled trial of porcine secretin in autism","volume":"40","author":"Owley","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0011|cit11","first-page":"e1006","article-title":"A double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder","volume":"1","author":"Owley","year":"1999","journal-title":"Medscape General Medicine"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0012|cit12","volume-title":"Effects of repeated secretin administration on a subset of children with pervasive developmental disorder [PhD dissertation]","author":"Krusch","year":"2004"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0013|cit13","unstructured":"Repligen Corporation Repligen Announces Initiation of Phase 3 Clinical Trials for Secretin in Autism Press release"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1542\/peds.107.5.e71","article-title":"Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial","volume":"107","author":"Roberts","year":"2001","journal-title":"Pediatrics"},{"issue":"24","key":"10.1002\/14651858.CD003495.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199912093412404","article-title":"Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder","volume":"341","author":"Sandler","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1651-2227.2002.tb03274.x","article-title":"Multiple doses of secretin in the treatment of autism: a controlled study","volume":"91","author":"Sponheim","year":"2002","journal-title":"Acta Paediatrica"},{"issue":"11","key":"10.1002\/14651858.CD003495.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00004583-200211000-00012","article-title":"A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism","volume":"41","author":"Unis","year":"2002","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0018|cit18","unstructured":"Wray J Wilkins-Shurmer A O'Connor G Knott H Bint L Gilroy A Lack of communication and behavioural response of children with autism from single dose of intravenous porcine secretin Unpublished"},{"issue":"2","key":"10.1002\/14651858.CD003495.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1020778108068","article-title":"Secretin and sleep in children with autism","volume":"33","author":"Honomichl","year":"2002","journal-title":"Child Psychiatry and Human Development"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1542\/peds.108.5.e90","article-title":"Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study","volume":"108","author":"Lightdale","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003495.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13590840020013257","article-title":"A clinical study of secretin in autism and pervasive developmental delay","volume":"10","author":"Lonsdale","year":"2000","journal-title":"Journal of Nutritional and Environmental Medicine"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0022|cit22","unstructured":"NCT00036231 A phase III, randomized, double blind, placebo-controlled, multiple dose study to assess the efficacy, safety and tolerability of RG1068 (synthetic human secretin) in children with autism and gastrointestinal dysfunction [Study terminated] ClinicalTrials.gov: www.clinicaltrials.gov\/ct2\/show\/NCT00036231"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0023|cit23","unstructured":"Repligen Corporation Phase 3 study for secretin for autism fails to meet dual primary endpoints. Development of secretin for schizophrenia to continue Press release"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1362361305053257","article-title":"Randomized controlled trial of transdermal secretin on behavior of children with autism","volume":"9","author":"Ratliff-Schaub","year":"2005","journal-title":"Autism"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0025|cit25","first-page":"173","article-title":"Double blind crossover study of secretin\/secrepan treatment for children with autistic symptoms","volume":"12","author":"Shin-Siung","year":"2000","journal-title":"Tzu Chi Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/1064-1297.16.3.191","article-title":"Increased amygdala fMRI activation after secretin administration","volume":"16","author":"Yurgelun-Todd","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology."},{"key":"10.1002\/14651858.CD003495.pub3-BIB0027|cit27","volume-title":"Manual for the Child Behavior Checklist \/4-18, 1991 Profile","author":"Achenbach","year":"1991"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0028|cit28","volume-title":"Aberrant Behaviour Checklist (ABC)","author":"Aman","year":"1986"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0029|cit29","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0030|cit30","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0196-9781(83)90029-3","article-title":"Secretin modulation of behavioural and physiological functions in the rat","volume":"4","author":"Charlton","year":"1983","journal-title":"Peptides"},{"issue":"7109","key":"10.1002\/14651858.CD003495.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test [see comments]","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0033|cit33","article-title":"Words and sentences","volume-title":"MacArthur Communicative Development lnventories (CDI)","author":"Fenson","year":"1993"},{"issue":"4","key":"10.1002\/14651858.CD003495.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0033291799008508","article-title":"The epidemiology of autism: a review","volume":"29","author":"Fombonne","year":"1999","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.289.1.87","article-title":"The prevalence of autism","volume":"289","author":"Fombonne","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD003495.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","article-title":"Epidemiology of pervasive developmental disorders","volume":"65","author":"Fombonne","year":"2009","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-7138(09)60610-5","article-title":"A scale for rating symptoms of patients with the syndrome of autism in real life settings","volume":"25","author":"Freeman","year":"1986","journal-title":"Journal of the American Academy of Child Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0196-9781(81)90054-1","article-title":"Secretin immunoreactivity in rat and pig brain","volume":"2","author":"Charlton","year":"1981","journal-title":"Peptides"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0039|cit39","volume-title":"Expressive One-Word Picture Vocabulary Test (Revised)","author":"Gardener","year":"1990"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0040|cit40","first-page":"291","article-title":"The neurology of autism","volume-title":"The Biology of Autistic Syndromes","author":"Gillberg","year":"2000"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0041|cit41","volume-title":"The Gilliam Autism Rating Scale (GARS)","author":"Gilliam","year":"1995"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0042|cit42","first-page":"217","volume-title":"Early Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology. Revised","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0043|cit43","volume-title":"Developmental Test of Visual Perception (DTVP-2)","author":"Hammill","year":"1993"},{"issue":"11","key":"10.1002\/14651858.CD003495.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0045|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0046|cit46","first-page":"9","article-title":"Improved social and language skills after secretin administration in patients with autistic spectrum disorders","volume":"9","author":"Horvath","year":"1998","journal-title":"Journal of the Association for Academic Minority Physicians"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0047|cit47","first-page":"217","article-title":"Autistic disturbances of affective contact","volume":"2","author":"Kanner","year":"1943","journal-title":"Nervous Child"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1023\/A:1020546006971","article-title":"Assessing change in early intervention problems for children with autism","volume":"32","author":"Kasari","year":"2002","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.1542\/peds.2011-0428","article-title":"A systematic review of secretin for children with autism spectrum disorders","volume":"127","author":"Krishnaswami","year":"2011","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0050|cit50","volume-title":"Autism Screening Instrument for Educational Planning","author":"Krug","year":"1980"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0051|cit51","volume-title":"Leiter International Performance Scale Instruction Manual (revised edition)","author":"Leiter","year":"1980"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0052|cit52","volume-title":"Peabody Picture Vocabulary Test - Third Edition (PPVT-III)","author":"Lloyd","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0054|cit54","volume-title":"Autism Diagnostic Observation Scale - Generic","author":"Lord","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism","volume":"30","author":"Lord","year":"2000","journal-title":"Journal of Autism and Developmental Disorders."},{"issue":"15","key":"10.1002\/14651858.CD003495.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0057|cit57","volume-title":"Mullen Scales of Early Learning","author":"Mullen","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.2007-2362","article-title":"Management of Children with Autism Spectrum Disorders","volume":"120","author":"Myers","year":"2007","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0059|cit59","first-page":"1069","article-title":"Treatment Emergent Symptoms Scale -- write-in (TESS)","volume":"21","author":"National Institute of Mental Health","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0060|cit60","volume-title":"Evidence-Based Practices for Children and Adolescents with Autism Spectrum Disorders: Review of the Literature and Practice Guide","author":"Perry","year":"2003"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0061|cit61","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2005"},{"issue":"2","key":"10.1002\/14651858.CD003495.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1005447203394","article-title":"Comments on \"Secretin and autism: a two-part clinical investigation\" by M.G. Chez et al","volume":"30","author":"Rimland","year":"2000","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0063|cit63","doi-asserted-by":"crossref","DOI":"10.1037\/e506622012-001","volume-title":"A review of the Research to Identify the most Effective Models of Practice in Early Intervention of Children with Autism Spectrum Disorders","author":"Roberts","year":"2006"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02408436","article-title":"Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)","volume":"10","author":"Schopler","year":"1980","journal-title":"Journal of Autism and Developmental Disorder"},{"issue":"3","key":"10.1002\/14651858.CD003495.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jpepsy\/19.3.325","article-title":"Minnesota Preschool Affect Rating Scales: development, reliability, and validity","volume":"19","author":"Shapiro","year":"1994","journal-title":"Journal of Pediatric Psychology"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0066|cit66","volume-title":"Assessment in Speech-Language Pathology","author":"Shipley","year":"1992"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0067|cit67","volume-title":"Assessment, Diagnosis and Clinical Interventions for Children and Young People with Autism Spectrum Disorders. A National Clinical Guideline","author":"Scottish Intercollegiate Guidelines Network","year":"2007"},{"issue":"5","key":"10.1002\/14651858.CD003495.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00004583-200405000-00008","article-title":"The developmental, dimensional and diagnostic interview (the 3di): a novel computerised assessment for autism spectrum disorders","volume":"43","author":"Skuse","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0069|cit69","volume-title":"Vineland Scales of Adaptive Behavior, Survey Form Manual","author":"Sparrow","year":"1984"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0070|cit70","volume-title":"Mental Measurement of Preschool Children with a Guide for the Administration of the Merrill-Palmer Scale of Mental Tests","author":"Stutsman","year":"1931"},{"issue":"7321","key":"10.1002\/14651858.CD003495.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vicker","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0072|cit72","volume-title":"Communication and Symbolic Behaviour Scales (CSBS)","author":"Wetherby","year":"1993"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0073|cit73","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","author":"World Health Organization","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD003495.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/adc.2004.062083","article-title":"Systematic review of prevalence studies of autism spectrum disorders","volume":"91","author":"Williams","year":"2006","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0075|cit75","volume-title":"Diagnostic Interview for Social and Communication Disorders (DISCO)","author":"Wing","year":"1999"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0076|cit76","volume-title":"Pre-school Language Test (PLS-3)","author":"Zimmerman","year":"1992"},{"key":"10.1002\/14651858.CD003495.pub3-BIB0077|cit77","doi-asserted-by":"crossref","unstructured":"Williams KJ, Wray JJ, Wheeler DM. Intravenous secretin for autism spectrum disorder. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003495. DOI: 10.1002\/14651858.CD003495.pub2","DOI":"10.1002\/14651858.CD003495.pub2"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003495.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:32:27Z","timestamp":1735839147000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003495.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":77,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003495.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}